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Abstract 
Assessment of West Virginia public health professionals’ knowledge, attitudes and behaviors 
regarding of the oral implications of HPV following an educational presentation. 
 
Renee Cooper-Frantz 
 
 Human Papillomavirus (HPV), the most common sexually transmitted infection in the 
United States, was firmly linked to a new subset of oropharyngeal squamous cell carcinomas 
(OSCC’s) in late 2007. With growing rates of West Virginians affected by HPV-related oral 
cancers it becomes pertinent to verify that public healthcare professionals of all disciplines are 
aware of this causal relationship and educating their patients. The purpose of this study was to 
determine the knowledge level, attitudes and behaviors of a convenience sample of West 
Virginia’s public healthcare professionals regarding the oral implications of HPV before and 
after and educational presentation. A pre- and post- intervention survey methodology was 
utilized with an additional survey mailed to the sample population four months later. Chi-square 
tests for independence and binary logistic regression were utilized to determine any significant 
differences of answer choice on all three surveys. Statistical analysis revealed a significant 
increase in knowledge concerning oral cancer related to HPV on two of the three survey 
questions (X2= 6.4, p=0.03, X2=6.3, p=0.02). After the educational lecture participants indicated 
they were more likely to engage and educate the public about oral cancer caused by HPV (X2= 
4.2, p =0.08), encourage their at-risk patients to seek oral cancer screenings (X2=2.1, p=0.18) 
and claim to have taken every opportunity to speak with patients about oral cancer caused by 
HPV (X2=14.5, p=0.0001). Knowledge of and patient education efforts by West Virginia public 
healthcare providers concerning the oral implications of HPV has increased as a result of the 
lecture. The knowledge gain indicated knowledge deficiencies on the topic which indicates the 
topics’ future application for interprofessional education (IPE). It is recommended that this topic 
be applied to IPE in other states or within other settings such as the correctional environment or 
Native American reservations.  
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Chapter 1: Introduction 
Purpose of the Study 
 The purpose of this study was to determine the knowledge level, attitudes and behaviors 
of a convenience sample of West Virginia’s public healthcare professionals regarding the oral 
implications of HPV before and after and educational presentation. 
Operational definitions: 
Interprofessional education (IPE): When students from two or more professions learn about, 
 from and with each other to enable effective collaboration and improve health outcomes 
 (WHO, 2010). 
Continuing interprofessional education (CIPE): Formal postlicensure interprofessional education. 
Oropharyngeal squamous cell carcimoma (OSCC): Carcinoma of the squamous cells associated 
 with the oropharynx (i.e. anatomical structures include the palatine tonsils, the base of the 
 tongue, and the area between the palatine tonsils and the larynx). 
Public healthcare professionals: medical and dental professionals involved in direct patient care 
 at a public health department within the state of West Virginia. 
Research Questions 
 Are public health professionals, employed by the West Virginia State Department of Health 
(n~370) aware of information concerning the relationship between oropharyngeal cancers 
and HPV?  
 Are they aware of available HPV-specific oral cancer detection strategies?  
 Are the patients they see at-risk for developing oral cancer related to HPV?  
 In their opinion, are they educating their patients about this infectious relationship? 
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Significance of Study 
 At the time of this project, no other research has been conducted on this subject with this 
sample population. To date, information concerning the knowledge, attitudes or behaviors of 
public health professionals is unknown. To ensure adequate education of public health 
professionals, it is necessary to discern their current level of knowledge to fine tune future 
educational initiatives, specifically IPE.  
 Human Papillomavirus (HPV), the most common sexually transmitted infection in the 
United States, was found to be directly related to a new subset of oropharyngeal squamous cell 
carcinomas (OSCC’s) in late 2007 (Centers for Disease Control and Prevention (CDC), 2014; 
D’Souza et al., 2007). There were 1,263 oropharyngeal cancers in West Virginia from 2005 to 
2009, 903 of which were males (West Virginia Department of Health and Human Resources 
(WV DHHR), 2012). HPV-associated oropharyngeal cancer rates in West Virginia from 2006-
2010 for females were 1.60-1.93 (per 100,000) and for males were 6.09-7.03 (per 100,000) 
(CDC, 2014).  
 Since West Virginians exceed the national rate for persons affected by oral cancers 
related to HPV, it becomes pertinent to verify that public healthcare professionals of all 
disciplines are aware of its relationship. IPE is suggested as a means to share information that 
concerns multiple disciplines with the common goal of improving patient safety and welfare.  
Assumptions  
 The participants are truthfully answering the questions to the best of their knowledge and 
ability.   
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Limitations 
 There can be no assurance that the sample, taken over two different presentation sessions, 
does not include some of the same individuals.  
 Because of the anonymous nature of the study there was also no assurance the follow-up 
surveys reached the same participants that witnessed the presentation as they were simply 
sent the public health department that they reported they were from for attendance purposes 
at the continuing education course that hosted the presentation.  
 Also, unbeknownst to the researcher, copies of the presentation were supplied to the potential 
participants prior to the start of the presentation and they therefore had access to information 
that could have been used to answer the knowledge-based questions. 
 Limited reliability and validity of the measurement instruments (surveys) due to limited 
preliminary testing. 
Delimitations 
 The study frame included a convenience sample of public health professionals only from 
West Virginia attending a continuing education course which enabled results specificity to 
the state. 
 Public healthcare professionals were chosen as subjects in this study due to their knowledge 
of and proximity to healthcare concerns specific to their patients, the general public. 
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Chapter 2: Review of Literature 
Introduction 
 Human Papillomavirus (HPV) is a proven cause of a new subset of oropharyngeal 
squamous cell carcinoma (OSCC) (D’Souza, 2007).  Strain 16 is linked to the majority of HPV 
positive OSCCs and is included in both prophylactic HPV vaccinations (Kriemer, 2005; Food 
and Drug Administration (FDA), 2009). HPV-associated oropharyngeal cancer rates in West 
Virginia from 2006-2010 for females were 1.60-1.93 (per 100,000) and for males were 6.09-7.03 
(per 100,000) (Centers for Disease Control and Prevention [CDC], 2014). As HPV related oral 
cancers become more common it is imperative that public healthcare providers are 
knowledgeable about the connection and are able to advise patients appropriately. There are 
several screening methods for HPV related oral cancer that can be recommended to at risk 
patients (males, those that have had more than 6 oral sex partners, or are immunocompromised)  
(D’Souza G., 2007; Kreimer, 2004; Smith E., 2004).  This health concern requires involvement 
of multiple healthcare disciplines from primary care, dental, and pathology, to oncology. The 
application of this topic during IPE events, and multidisciplinary educational events that promote 
responsive and relevant communication to improve patient safety and treatment, could greatly 
increase familiarity, confidence and inspire a team-based approach (Institute of Medicine, 2010).  
Historic Perspectives of HPV 
 HPV is currently the most common sexually transmitted disease and is a collection of 
more than 100 viruses; most strains (60%) cause warts or are eliminated by the immune system 
while the remaining (40%) can cause cancer (CDC, 2009; American Cancer Society, 2009). It is 
estimated that HPV is responsible for almost all cervical cancers, 95% of anal cancers, 65% of 
vaginal cancers, 60% of oropharyngeal cancers, 50% of vulvar cancers, and 35% of penile 
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cancers (CDC, 2013b). HPV infections can remain unexpressed or latent for 20 years or more, 
making increased transmission of the HPV virus between sexually active individuals a notable 
concern as it can be transmitted without any current signs or symptoms (Watson, 2005; 
McIllhaney, 2000).  
HPV Vaccinations  
 In 2006, a quadrivirulant vaccine was developed to prevent the four most harmful and 
prevalent strains of HPV (Food and Drug Administration [FDA], 2014). The vaccine includes 
strains 6 and 11 (which cause 90% of genital warts) and strains 16 and 18 (which cause 70% of 
cervical cancer). It has been approved for males and females ages nine to twenty six years old 
and has been proven to be close to 100% effective when administered before any contact with 
the viruses (American Cancer Society, 2009; CDC, 2012; FDA, 2009). In 2009, another 
prophylactic vaccine was introduced and includes HPV16 and 18, therefore only protecting 
against cervical cancer. The FDA approved the second HPV vaccine for use in males and 
females ages ten to twenty five years old with an estimated efficacy of 93% when administered 
before any exposure to HPV (FDA, 2009).    
 In 2011 less West Virginia females age 13-17 had received ≥3 of the HPV vaccine trilogy 
than those in the United States (28.6% WV, 34.8% US) (Morbidity and Mortality Weekly Report 
(MMWR), 2012). However, by 2013 more West Virginian females and males age 13-17 had 
received ≥3 of the HPV vaccines than nationally (females: 38.4% WV, 37.6% US; males: 15.1% 
WV, 13.9% US) (MMWR), 2014). From 2007 to present 42,084 West Virginian patients have 
completed all three injections of either HPV vaccine with 21,589 being done in the private sector 
and 20,495 in the public sector, which includes health departments.  
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Oropharyngeal cancer and HPV 
Risk factors 
 Smoking and alcohol use do not increase the risk of HPV16 associated oropharyngeal 
cancer however, a high lifetime number of vaginal sex partners (twenty six or more) or a high 
lifetime number of oral sex partners (six or more) was associated with HPV-related 
oropharyngeal cancer (Applebaum K., 2007; D’Souza et al., 2007). Gonçalves (2006) concluded 
that patients having lower levels of IgA in their saliva were more susceptible to both genital and 
oral HPV infections. HPV is known as an opportunistic oral infection and is seen more 
frequently in the immunocompromised, regardless of level or severity of immunosuppression 
(Leigh, et al., 1999). 
Transmission and Appearance 
 Transmission of HPV to the oral cavity is made possible when a viable route or contact 
(oral sex) occurs and is combined with a suitable environment (oral mucosa) in a susceptible host 
(sexually active individual) (Syrjanen, 2003). To clarify, the main route of oral HPV 
transmission is through oral sex, including both fellatio and cunnilingus and some forms of deep 
kissing (Gillison, 2012; Martin-Hernan, Sanchez-Hernandez, Cano, Campo, & del Romero, 
2013). 
  Clinically, cancerous lesions on the tonsils can appear as white plaques (leukoplakia), 
indurated ulcers, or bulky multi-lobed exophytic growths (Weiland, 1997; Young, 2007). These 
lesions most often occur on the anterior tonsillar pillars (American Cancer Society, 2009; Yanjia, 
2007). If HPV is involved, the exophytic growths could look cauliflower-like with multiple lobes 
and either sessile or pedunculated bases, similar to those seen in genital warts (Syrjanen, 2003). 
Clinically, a tumor formed in the oropharynx can look very similar, regardless of the carcinogen. 
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Therefore the patient’s health history and a biopsy of the tumor are the most accurate ways to 
determine the cause (National Cancer Institute, 2011). 
Prognosis 
  Oropharyngeal cancer has a 50% survival rate within the first five years after diagnosis 
but has increased survival rates when identified and treated earlier (National Cancer Institute, 
2011). Although HPV-associated cancers are commonly detected in advanced stages of disease, 
most cases that contain HPV have a better prognosis with typical radiation or chemotherapy for 
unknown reasons (Smith E., 2004; D’Souza et al., 2007; Klozar, 2008).  
National oral HPV prevalence 
 In 2009 nationwide oral HPV prevalence in both males and females ages 14-69 was 6.9% 
with HPV 16, the primary cancer causing strain, accounting for 1.0%  with peak prevalence 
occurring at ages 31-34 years (7.3%, 95% CI, 4.6%-11.4%) and 60-64 years (16.4%, 95% CI, 
8.5%-15.1%) (Gillison et al., 2012). The incidence of HPV-positive oropharyngeal cancer 
increased in the United States by 225%, especially in younger populations since the 1950s 
(Chaturvedi, 2011).  
Oral HPV prevalence in West Virginia 
 From 2005-2009 there were 1,263 oropharyngeal cancers in West Virginia, 903 of which 
were males (WV DHHR, 2012). HPV-associated oropharyngeal cancer rates in West Virginia 
from 2006-2010 for females were 1.60-1.93 (per 100,000) and for males were 6.09-7.03 (per 
100,000) (CDC, 2014).   
Early Detection of HPV-associated oropharyngeal cancer 
 Although the standard of care dental professionals currently perform oral cancer 
screenings on a varied basis depending on professional preferences or patient request. These 
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screenings include a visual exam of all sides of the tongue, buccal mucosa of the cheeks, 
vestibular mucosa and palpation of the floor of the mouth and lymph nodes along the neck 
(Sapp, 2004). This type of screening tends to be useful for identifying visible or palpable 
changes in the mucosa consistent with a cancerous lesion, however visible lesions tend to be 
identified in the later stages of metastasis (D’Souza G., 2007). Palpation searches for nodular 
formations are often inconclusive considering there are enumerable other less-threatening 
nodular formations such as swollen lymph nodes due to allergies or colds, mucoceles, sialoliths, 
or draining fistulas which are unrelated to oral cancer (Sapp, 2004). Likewise, blood titers would 
be able to identify a positive result for HPV antibodies which could indicate the presence of the 
HPV vaccine or natural resistance to a past or current infection and therefore would not be useful 
as an HPV screening tool specific to the oral cavity. 
 Salivary diagnostics have quickly been recognized by the medical community as an easy 
and less invasive way to collect DNA samples for many uses. Salivary diagnostics are now able 
to detect the presence of HPV strains in the oral cavity. Many companies now boast a specific 
HPV test that uses the patient’s saliva either through a saline rinse or a saliva soaked cotton 
patch (Shirtcliff, 2001).  Most tests work by utilizing Polymerase Chain Reaction (PCR) assays 
which identify specific viral DNA strands (Walline, et al., 2013).   
 A new handheld device uses fluorescence technology to identify submucosal cellular 
changes by exposing a normal or suspicious intra-oral area to blue wavelength visible light. 
Normal tissues glows apple green under the blue light while areas with cellular changes will 
appear dull, darkened or sometimes dark brown (Thong, 2009). This development enables dental 
professionals to non-invasively screen patients for submucosal changes that are not clinically 
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visible. Although the test is efficient at identifying cellular changes, it is not specific to the cause 
of cellular changes and therefore requires additional diagnostic tests.  
Behavior Change Models and  Interprofessional Education 
 According to several social and behavioral change models the first stage typically 
addresses the presence or lack of knowledge. Specifically, the Knowledge-Attitude-Behavior 
model and the Health Belief model rely on current knowledge level to influence attitudes, 
perceived susceptibility and perceived seriousness (Baronowski, 2003; Griffith, 2011). Thus, 
health care providers must be knowledgeable to impart adequate instructions to patients to enable 
their patients to make informed health decisions. As education concerning oral cancers related to 
HPV concerns many health disciplines it would be an ideal topic for interprofessional education 
(IPE) and collaborations. 
 IPE was developed to aid in the sharing of pertinent health information by inviting 
multiple disciplines to educational events to improve collaboration and quality of patient care 
(WHO, 2010). The core competencies of IPE guide many collaborative efforts and are as 
follows:  
 1. Work with individuals of other professions to maintain a climate of mutual respect and 
 shared values;  
 2. Use the knowledge of one’s own role and those of other professions to  appropriately 
 assess and address the healthcare needs of the patients and populations served;  
 3. Communicate with patients, families, and communities, and other health 
 professionals in a responsive and responsible manner that supports a team approach to the 
 maintenance of health and the treatment of disease;  
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 4. Apply the relationship-building values and the principles of team dynamics to perform 
 effectively in different team roles to plan and deliver patient/population-centered care 
 that is safe, timely, efficient,  effective, and equitable (IPE Collaborative Expert Panel, 
 2011).  
While the idea of IPE faces many intrinsic and extrinsic challenges studies suggest there is 
potential for improvements in patient health and safety to occur as a result of this collaboration 
(Coleman, 2005; Thistlethwaite, 2012).  
 Some advocate the combining of continuing education with IPE to create continuing 
interprofessional education (CIPE). The combination training would not only provide continuing 
education at more routine intervals but could encourage multidisciplinary working relationships. 
New knowledge is retained best when presented on a contracting schedule or at decreasing 
intervals from introduction to examination (Kupper-Tetzel, Kapler, Wiseheart, 2014). Regardless 
of educational schedule knowledge retention has been shown to decline approximately 20-30% 
in 35 days (Kupper-Tetzel, Kapler, Wiseheart, 2014). Furthermore, knowledge retention 
decreases substantially with nonpractices or nonuse especially for cognitive and accuracy-based 
tasks (Arthur, Bennett, Stanush, McNelly, 1998).  
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Chapter 3: Procedures and Methodology 
Introduction 
 Annually, West Virginia’s public health professionals gather for the purpose of obtaining 
continuing education for state and national licensure requirements. These events were not CIPE 
or IPE events although several disciplines were present. Continuing education events became the 
venues for the study due to the ability to convenience sample public health professionals and 
present the educational intervention. The survey method of information gathering was selected 
due to its ability to be quick administration, anonymous nature and ease of use.  
 Three surveys were designed to be administered before, immediately after and four 
months after an educational presentation during a public health continuing education seminar. 
Surveys included dichotic, multiple choice and multiple-multiple choice questions. Surveys also 
included Likert-scale questions designed to describe attitudes, with five answer choices that 
ranged from Strongly Agree to Strongly Disagree. These questions had similar format to 
knowledge, attitude and perception surveys therefore having similar reliability and validity. 
Surveys were critiqued by corrected by several faculty involved in survey research. 
 In this study a pre- and post- intervention survey method was utilized with an additional 
mailed survey that is identical to the post-intervention survey [Appendix A: Surveys]. The pre-
intervention survey gathered demographic data and established knowledge and perceived 
behavioral habits. The post-intervention and mailed follow-up survey were identical and 
designed to establish knowledge gain and/or retention over time as well as attitude or perceived 
behavioral changes.  
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Procedures 
 Implementation of this study began with introduction of the study to those present and the 
anonymous nature and IRB compliance was explained. Although the presentation was scheduled 
with the nursing section of the continuing education event, other available disciplines were 
invited to attend. The study was not included on the continuing education events’ itinerary but 
the slides were printed beforehand and given to the participants. 
  Implied consent was expressed by participants completing the surveys after having read 
the cover letter. The intervention, an educational ten minute Powerpoint presentation, was 
provided between the pre- and post-intervention surveys. Participants were given five to ten 
minutes to complete each survey during the 30 minute presentation time slot. 
 At the close of the presentation, a question and answer session covering presented content 
was conducted and surveys were collected. Informational handouts on oral cancer related to HPV 
were provided after the presentation along with the ‘Oral Cancer’ brochure available from the 
National Health Institute to interested participants. A volunteer from the event’s management of 
the continuing education event provided a numerical list of public health professionals attending 
the lecture from each health departments represented. This information was utilized to mail the 
follow-up survey to potential participants.  
 The follow-up survey with prepaid return postage was sent via postal service to their 
respective health departments. As their names were unknown it was taken upon the mail 
reviewer at each health department to deliver the survey to the actual participant. A cover 
different letter included directions, a short explanation of the study, and reiteration of the 
anonymous nature were included with the follow-up survey. Responding participants were 
mailed a fifteen dollar gift card from their choice of four pizza restaurants. 
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Subjects 
 All participants were above the age of 18. The participants of this study consisted of a 
convenience sample of public health professionals, including any clinical and non-clinical health 
related profession, employed at one of 53 public health departments within the state of West 
Virginia.  
Statistical Analysis 
 Descriptive statistics were utilized to achieve an overall picture of their patients’ 
demographics and determine if these patients fit the predetermined at-risk populations. 
Participant demographics and overall trends in frequently selected answers were also described 
using descriptive statistics. One variable was created to ascertain differences within the sample 
between answer choices of nurses versus non-nurses.  
  Five questions appeared on all three surveys; three knowledge based questions and two 
Likert-scale questions. All questions were analyzed on participants’ positive response, i.e. 
answered correctly on the knowledge questions or answered strongly agree on the attitude 
questions. The chi square test of independence was selected for use due to its ability to measure 
association of dichotomous answer choices to the nursing variable. An alpha level of 0.05 was 
used for all statistical tests and Fisher’s p-value was reported when values were less than five.  
 Binary logistic regression was used to predict relationships between nurses answer 
choices on all three surveys simultaneously. For all logistic regression the degrees of freedom 
were equal to one. The chi-square value reported with the logistic regression results was the 
Wald statistic. 
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Chapter 4: Results 
Descriptive Data 
 The seventy five participants represented 33 health departments and seven public health 
agencies within West Virginia. This sample represents approximately 20% of the total 
community health workers and 62% of state health departments (United States Department of 
Labor, 2014). The mailed follow up surveys had a response rate of 48% from the first session, 
95% from the second session for a combined response rate of 76%. The majority of participants 
were nurses, ages 40-59 with either an Associate’s degree or above (see Figure 1.1). 
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Figure 1.1 Sample Demographics
 
 Perceptions about the populations served by participants were gathered on the 
preliminary survey. Practitioners estimated that of the patients they see approximately 10-50% of 
them have been diagnosed with HPV and approximately 70% of their patients are under 30 years 
old. Slightly under half of participants (46%) stated they spend less than 10% or between 10-
30% of their time speaking with patients about HPV however, 34% stated they recommend the 
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HPV vaccines anywhere from 30-70% of the time. In addition, 20% stated they recommend the 
vaccines less than 10% of the time while 21% of participants stated they recommend HPV 
vaccinations 90-100% of the time (see Figure 1.2). 
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Figure 1.2 Frequency of Reported Patient Demographics
 The overall frequency of correctly answered knowledge based questions decreased from 
the pre-intervention to the follow-up survey for the entire sample. One attitude question showed 
a similar decline of favorable agreement with the statement. Conversely, Question 5 showed an 
increase of agreement to the statement by 20 responses. 
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Figure 1.3 Frequency of Correct Answers
Question 1: HPV can cause the following:
Question 2: Oral cancer caused by HPV can be detected in the following ways:
Question 3: According to D’Souza what is considered a high lifetime number of 
oral-sex partners?
Question 4: I am knowledgeable about the potential for HPV to cause oral
cancers.
Question 5: In the past 3 months I have taken every opportunity to speak with
patients about the potential of HPV causing oral cancer.
 
 Chi Square test for Independence 
 A chi square test of independence was performed to determine the possible relationships 
between nurses’ answers on each of the consistent five questions. Results indicate that nursing 
professionals were more likely to answer Question 1 and Question 3 correctly on the follow up 
survey than non-nurses, X2=6.48, p=0.03, X2=6.32, p=0.02, respectively. Similarly, they were 
more likely to answer Question 2 correctly on the pre-intervention survey, X2=4.51, p=0.05. 
Nurses were more likely to strongly agree with the fifth consistent question on the follow up 
survey than other professions, X2=14.51, p=0.0001. Nurses’ agreement to the statement 
17 
 
describing their perceived patient education behaviors in the last three months increased over 
time, Figure 2.1.  
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Figure 2.1 Question 5: In the past 3 months I have taken 
every opportunity to speak with patients about the 
potential of HPV causing oral cancer.
p=0.4095 p=0.3492
p=0.0001
 
 Chi-square analysis of attitude questions did not reveal any statistically significant 
relationships. For all attitude questions, except the second question, there was some degree of 
increased agreement determined by the increase in chi-square values on the follow up surveys. 
The second attitude question asked if professional behaviors were likely to be affected as a result 
of the lecture. Initially nurses agreed with the statement (X2=3.6, p=0.06) but agreement 
decreased on the follow up (X2=1.1, p=0.48).  
Binary Logistic Regression 
 The predictive model indicated that the variable for nurses was significantly different 
than the model on Question 4 of the follow up survey (X2=5.3 p=0.02, OR=6.2). For the 
remainder of consistently asked questions the logistic regression results suggest no statistically 
significant changes occurred before, after or 4 months after presenting the informational 
presentation (Appendix: Table 3).   
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Chapter 5: Discussion and Conclusions 
Summary of Findings 
 Overall, the statistical analysis of all three surveys may support the research hypothesis 
stating that changes in knowledge and attitude have occurred because of exposure to the 
informational presentation. The most profound result of this study indicates that the presentation 
encouraged 71% of the sample to change their behavior and are now educating their patients 
more about oral cancers related to HPV. This result could be used to encourage future 
interprofessional education events on this topic to help continue to improve communication with 
patients, families, communities and other professionals. 
Discussion 
 The frequency data reveals a possible contradiction between the responses. 
Approximately half of the responses indicated that they recommend the HPV vaccination 90-
100% of the time while the other half indicated they recommend it less than 10%. A noticeable 
trend in the data was nonresponse for clinical based questions meant for nurses only. 
Nonresponse accounted for approximately 25% of responses even though an ‘Unknown’ option 
was included for all of those questions.  
 The chi square results for two of the three consistently asked knowledge based questions 
increased over time from the pre-intervention survey to the follow-up. The significant increase 
suggests an improvement on previously held knowledge. While overall knowledge of nurses 
increased over time the observed effect may be, in part, due to the reuse of the post-survey as the 
follow-up survey thereby possibly creating familiarity and false positive results. The one 
instance where knowledge level decreased over time may suggest that some information 
presented in the lecture was unclear. This decrease could also reassure that the results were not 
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subject to bias created by question familiarity. Statistical analysis of attitudes toward perceived 
knowledge on the topic were inconclusive and may suggest an uncertainty of their knowledge 
level. 
 Chi square analysis of the attitude questions included on the post-intervention and follow 
up surveys showed improvement although not statistically significant. After the educational 
presentation participants indicated they were more likely to engage and educate the public about 
oral cancer caused by HPV and encourage their at-risk patients to seek oral cancer screenings. 
This slight change in behavior indicates the potential impact of IPE on current heath care topics. 
Communication in all areas, between all individuals, is integral to achieving the goals of IPE. 
The results of this study indicate that this level of communication is not only possible but is able 
to encourage behavior change. 
 Binary logistic regression revealed only one significant increase over time. Nurses’ felt 
stronger about their knowledge of oral cancers related to HPV over time which could be due to 
the information presented in the lecture or additional information sought in the time between the 
post-intervention survey and the follow-up survey. Logistic regression results were unable to be 
run on the post-intervention survey responses to Question 3 of the consistently asked questions 
due to model redundancy or an unexpectedly homogenous result; ninety one percent or 68 of 75 
participants answered this question correctly immediately following the lecture.  
Conclusions 
 Study results suggest the educational presentation had an overall positive effect on the 
participants’ knowledge, attitudes and behaviors.  
20 
 
 Participants have exhibited significant behavior change following the educational 
presentation specifically, 70% of participants are now educating their patients about the oral 
cancers related to HPV compared to 44% pre-intervention. 
 Retention of the knowledge over four months’ time was demonstrated on two of the three 
knowledge based questions. The indication that some knowledge was retained is encouraging 
but necessitates the need for future CIPE or IPE on this same topic. 
Recommendations for Further Research 
 Alterations of the same study design (one long in-depth educational presentation or a series 
of several small presentations over differing intervals of time with similar surveys) could 
better describe knowledge retention of this population.  
 The incorporation of a hands-on component, patient-communication tips for chairside 
education or development of discussion aids for patient education could encourage better 
knowledge retention through practical, kinesthetic learning. 
 Additional research could be done to discover the possible impact of public health 
professionals’ chairside education and their recommendations of the HPV vaccines on the 
prevalence of oral cancers related to HPV. The application of this topic to CIPE for other 
healthcare settings such as those in correctional institutions or Native American reservations 
has yet to be explored.
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Appendix A: Surveys  
Instructions: Please circle the answer that fits you and your beliefs the best. Answers to this survey 
are anonymous. In no way will these surveys be linked to you or affect your job. 
Age:  Under  20 21-30  31-40  41-50  51-60  61+ 
Gender: Male      Female      Prefer not to say 
Region:  I       II       III       IV       V      VI 
Professional Concentration:  Administration     Education      Dental       Nursing       Other:____________ 
Highest Level of Education:   High School Diploma      Associate        Bachelor        Master       Doctorate   
         Other:_____________ 
 
1. What is the age range of the majority of 
patients that you see? 
       Under 20  20-30  30-40  
       40-50  50-60   60+ 
2. I talk with patients about HPV what 
percentage of the time? 
<10%   10-30%   30-50%   50-70%   70-100% 
3. What percentage of the patients that you see 
do you recommend the HPV vaccines to? 
<10%  10-30%   30-50%   50-70%   70-100% 
If you are not a nurse you may skip to # 7. 
4. What is the age range of the majority of HPV 
positive patients that you see? 
 N/A  Under 20  20-30  30-40  
         40-50  50-60   60+   Unknown 
5. What percentage of the patients that you see 
have been diagnosed with HPV? 
 N/A    10-30%   30-50%   
           50-70%   70-100%    Unknown 
6. What percentage of the patients that you see 
have received the HPV vaccine? 
<10%   10-30%   30-50%   50-70%   70-100% 
Unknown 
7. Circle all that apply;    
HPV can cause the following: 
a) cervical cancer 
b) no signs or symptoms 
c) genital warts 
d) oral cancer 
 
 
8. Circle all that apply;     
Oral cancer caused by HPV can be detected in 
the following ways: 
a) salivary rinse 
b) blue light 
c) biopsy 
d) by feel 
e) blood titers 
f) visually 
9. According to D’Souza, what is considered a 
high lifetime number of oral-sex partners? 
a) 1-3 
b) 4-6 
c) 7-9 
10. I am knowledgeable about the potential of 
HPV to cause oral cancer.  
a) Strongly Agree 
b) Agree 
c) Undecided 
d) Disagree 
e) Strongly Disagree 
11. In the past 3 months I have taken every 
opportunity to speak with patients about the 
potential of HPV causing oral cancer. 
a) Strongly Agree 
b) Agree 
c) Undecided 
d) Disagree 
e) Strongly Disagree
 Post-Survey              
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Instructions: Please circle the answer that fits you and your beliefs the best. Answers to this survey 
are anonymous. In no way will these surveys be linked to you or affect your job. 
Age:              Under 20 21-30  31-40  41-50  51-60  61+ 
Gender: : Male    Female  Prefer not to say 
Region:  I       II       III       IV       V      VI  
Professional Concentration:  Administration     Education      Dental      Nursing      Other: ___________ 
Highest Level of Education:  High School Diploma      Associate       Bachelor        Master        Doctorate  
         Other: ________________ 
 
1. Circle all that apply;    
HPV can cause the following: 
a) cervical cancer 
b) no signs or symptoms 
c) genital warts 
d) oral cancer 
2. Circle all that apply;  
Oral cancer caused by HPV can be detected in 
the following ways: 
a) salivary rinse 
b) by feel 
c) blue light 
d) biopsy 
e) blood titers 
f) visually 
3. According to D’Souza, what is considered a 
high lifetime number of oral-sex partners? 
a) 1-3 
b) 4-6 
c) 7-9 
4. I am knowledgeable about the potential of 
HPV to cause oral cancer. 
a) Strongly Agree 
b) Agree 
c) Undecided 
d) Disagree 
e) Strongly Disagree 
6. The lecture on HPV and oral cancer will 
affect my personal behaviors. 
a) Strongly Agree 
b) Agree 
c) Undecided 
d) Disagree 
e) Strongly Disagree 
7. The lecture on HPV and oral cancer will 
affect my professional behaviors. 
a) Strongly Agree 
b) Agree 
c) Undecided 
d) Disagree 
e) Strongly Disagree 
8. In the future I will engage and educate the 
public about the link between HPV and oral 
cancer to my patients. 
a) Strongly Agree 
b) Agree 
c) Undecided 
d) Disagree 
e) Strongly Disagree 
9. After this course, I will encourage more of my 
patients with a high lifetime number of sexual 
partners to have oral cancer screenings. 
a) Strongly Agree 
b) Agree 
c) Undecided 
d) Disagree 
e) Strongly Disagree  
10. In the past 3 months I have taken every 
opportunity to speak with patients about the 
potential of HPV causing oral cancer. 
a) Strongly Agree 
b) Agree 
c) Undecided 
d) Disagree 
e) Strongly Disagree 
11. Would you like additional information 
related to HPV and its implications on oral 
health? 
a) Yes                      b)   No
 Follow up Survey      
 Preferred Pizza Gift Card:         Pizza Hut          Papa John’s          Fox’s Pizza Den          Dominos 
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Instructions: Please circle the answer that fits you and your beliefs the best. Answers to this survey 
are anonymous. In no way will these surveys be linked to you or affect your job. 
Age:  Under  20    21-30  31-40  41-50  51-60  61+ 
Gender: : Male      Female      Prefer not to say 
County: __________________________ 
Professional Concentration:   Administration      Education     Dental      Nursing      Other: ____________ 
Highest Level of Education:   High School Diploma     Associate      Bachelor         Master         Doctorate    
                    Other: ______________ 
1. Circle all that apply;    
HPV can cause the following: 
e) cervical cancer 
f) no signs or symptoms 
g) genital warts 
h) oral cancer 
2. Circle all that apply;  
Oral cancer caused by HPV can be detected in 
the following ways: 
g) salivary rinse 
h) by feel 
i) blue light 
j) brush biopsy 
k) blood titers 
l) visually 
3. According to D’Souza, what is considered a 
high lifetime number of oral-sex partners? 
d) 1-2 
e) 3-5 
f) 6 or more 
4. I am knowledgeable about the potential of 
HPV to cause oral cancer. 
f) Strongly Agree 
g) Agree 
h) Undecided 
i) Disagree 
j) Strongly Disagree 
5. The lecture on HPV and oral cancer affected 
my personal behaviors. 
f) Strongly Agree 
g) Agree 
h) Undecided 
i) Disagree 
j) Strongly Disagree 
6. The lecture on HPV and oral cancer affected 
my professional behaviors. 
f) Strongly Agree 
g) Agree 
h) Undecided 
i) Disagree 
j) Strongly Disagree 
7. Since the course, I have encouraged more of 
my patients with a high lifetime number of 
sexual partners to have oral cancer screenings. 
f) Strongly Agree 
g) Agree 
h) Undecided 
i) Disagree 
j) Strongly Disagree 
8. In the past 3 months I have taken every 
opportunity to speak with patients about the 
potential of HPV causing oral cancer. 
f) Strongly Agree 
g) Agree 
h) Undecided 
i) Disagree 
j) Strongly Disagree 
9. In the future I will engage and educate the 
public about the link between HPV and oral 
cancer. 
a) Strongly Agree 
b) Agree 
c) Undecided 
d) Disagree 
e) Strongly Disagree 
10. Would you like more information 
concerning oral cancer and HPV? 
a) Yes  b)    No 
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Appendix B: Statistical Tables 
 
 
 
Table 1: Demographics 
Age: 40% 51-60, 32% 41-50, 13% 31-40, 11% 61+, 4% 21-30 
Gender: 92% female, 4% no data, 3% prefer not to say, 1% male 
Professional Concentration: 72% Nursing, 13% Administration, 9% Dental, 3% Education, 
3% No data 
Highest Level of Education: 47% Associate, 39% Bachelor, 9% Master, 4% No data, 1% 
Doctorate 
 
Question Most common response (descending order) 
1: What is the age range of the majority of 
patients that you see? 
20-30 (42%), Under 20 (28%), No data 
(19%), 30-40 (8%), 40-50 (1%), 60+ (1%) 
2: I talk with patients about HPV what 
percentage of the time? 
<10% (25%), 10-30% (21%), 30-50% (19%), 
70-100% (17%) 50-70% (11%), No data (7%) 
3: What percentage of the patients that you 
see do you recommend the HPV vaccines to? 
90-100% (21%), <10% (20%), 30-50% 
(17%), 50-70% (17%), 10-30% (16%), No 
data (8%) 
Nursing only questions: 
4: What is the age range of the majority of 
HPV positive patients that you see? 
20-30 (47%), No data (26%), Under 20 
(15%), 30-40 (4%), 50-60 (4%), N/A (3%), 
Unknown (1%)  
5: What percentage of the patients that you 
see have been diagnosed with HPV? 
10-30% (27%), No data (24%), 30-50% 
(23%), Unknown (15%), 50-70% (7%), N/A 
(4%), 70-100% (1%) 
6: What percentage of the patients that you 
see have received the HPV vaccine? 
10-30% (31%), No data (26%), 30-50% 
(20%), <10% (12%), 50-70% (5%), Unknown 
(5%), 70-100% (0%) 
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Table 2: Chi square tests for independence between Nurses and answer choices 
Question 1: HPV can cause the following: 
 Pre Post  Follow-up 
Chi Square Values 0.1259 0.5250 6.4848 
P- Values 0.7076 0.4342 0.0269 
Phi coefficient 0.0437 0.0913 0.3183 
Question 2: Oral cancer caused by HPV can be detected in the following ways: 
 Pre Post  Follow-up 
Chi Square Values 4.5129 0.6409 0.2717 
P- Values 0.0480 0.7157 1.0000 
Phi coefficient 0.2615 -0.1009 0.0652 
Question 3: According to D’Souza what is considered a high lifetime number of oral-sex 
partners? 
 Pre Post  Follow-up 
Chi Square Values 0.0252 2.0724 6.3242 
P- Values 1.0000 0.3212 0.0178 
Phi coefficient -0.0196 -0.1814 0.3143 
Question 4: I am knowledgeable about the potential for HPV to cause oral cancers.  
 Pre Post  Follow-up 
Chi Square Values 1.8132 0.7810 5.3321 
P- Values 0.2271 0.4167 0.0542 
Phi coefficient 0.1657 0.1126 0.2886 
Question 5: In the past 3 months I have taken every opportunity to speak with patients about the 
potential of HPV causing oral cancer. 
 Pre Post  Follow-up 
Chi Square Values 0.6799 0.8765 14.5121 
P- Values 0.4096 0.3492 0.0001 
Phi coefficient 0.1015 0.1180 0.4762 
Caption: Italicized p-values indicate a Fisher’s p-value, bolded numbers indicate significance. 
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Table 3: Chi square Results for Attitude Questions 
Question 1: The lecture on HPV and oral cancer will affect my personal behaviors. 
Strongly agree and agree = 1     All others = 0 
 Post Follow-up 
Chi Square Values 0.0012 3.1385 
p- Values 0.9726 0.1004 
Phi coefficient -0.0043 0.02214 
Question 2: The lecture on HPV and oral cancer will affect my professional behaviors. 
Strongly agree = 1    Agree = 0 
 Post Follow-up 
Chi Square Values 3.6052 1.0559 
p- Values 0.0576 0.4786 
Phi coefficient 0.2373 0.1284 
Question 3:  In the future I will engage and educate the public about the link between HPV and 
oral cancer to my patients. 
Strongly agree = 1    Agree = 0 
 Post Follow-up 
Chi Square Values 1.4427 4.1584 
p- Values 0.2297 0.0803 
Phi coefficient 0.1501 0.2549 
Question 4:  After this course, I will encourage more of my patients with a high lifetime number 
of sexual partners to have oral cancer screenings. 
Strongly agree = 1     Agree = 0 
 Post Follow-up 
Chi Square Values 0.2748 2.0786 
p- Values 0.6001 0.1802 
Phi coefficient 0.0655 0.2619 
Caption: Italicized p-values indicate a Fisher’s p-value, bolded numbers indicate significance. 
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Table 4: Logistic Regression Results of Nurses answer choices across all 3 surveys 
Question 1:   Circle all that apply;   HPV can cause the following: 
 
Beta 
Standard 
Error 
Chi sq 
(Wald) 
Sig/pvalue 
Odds 
Ratio 
CI Lower 
CI 
Upper 
Intercept 0.00208 0.9152 0.0000 0.9982    
Pre 0.1434 0.6839 0.0440 0.8339 1.154 0.302 4.409 
Post 0.3634 0.7083 0.2632 0.6079 1.438 0.359 5.764 
Follow-
up 
0.8274 0.5365 2.3784 0.1230 2.287 0.799 6.547 
Question 2: Circle all that apply; Oral cancer caused by HPV can be detected in the following 
ways: 
 
Beta 
Standard 
Error 
Chi sq 
(Wald) 
Sig/pvalue 
Odds 
Ratio 
CI Lower 
CI 
Upper 
Intercept 1.1773 0.6682 3.1048 0.0781    
Pre 0.9272 0.6366 2.1216 0.1452 2.528 0.726 8.802 
Post -0.7633 0.7087 1.1601 0.2814 0.466 0.116 1.869 
Follow-
up 
1.0841 1.1128 0.9491 0.3300 2.957 0.334 26.187 
Question 3: According to D’Souza, what is considered a high lifetime number of oral-sex 
partners? 
 
Beta 
Standard 
Error 
Chi sq 
(Wald) 
Sig/pvalue 
Odds 
Ratio 
CI Lower 
CI 
Upper 
Intercept 0.9740 0.5494 3.1427 0.0763    
Pre 0.0597 0.5782 0.0107 0.9177 1.062 0.342 3.297 
Follow-
up 
-0.1195 0.5347 0.0500 0.8231 0.887 0.311 2.530 
Question 4:  I am knowledgeable about the potential of HPV to cause oral cancer. 
 
Beta 
Standard 
Error 
Chi sq 
(Wald) 
Sig/pvalue 
Odds 
Ratio 
CI Lower 
CI 
Upper 
Intercept 0.7251 0.3971 3.3346 0.0678    
Pre -0.0899 0.6649 0.0183 0.8924 0.914 0.248 3.364 
Post -0.3248 0.5590 0.3377 0.5612 0.723 0.242 2.161 
Follow-
up 
1.8316* 0.7978* 5.2701* 0.0217* 6.244* 1.307* 29.825* 
Question 5:  In the past 3 months I have taken every opportunity to speak with patients about 
the potential of HPV causing oral cancer. 
 
Beta 
Standard 
Error 
Chi sq 
(Wald) 
p-value 
Odds 
Ratio 
CI Lower 
CI 
Upper 
Intercept 1.3185 0.8963 2.1640 0.1413    
Pre -0.0795 0.5495 0.0209 0.8849 0.924 0.315 2.711 
Post -0.8042 0.8240 0.9524 0.3291 0.447 0.089 2.250 
Follow-
up 
0.5125 0.5773 0.7881 0.3747 1.669 0.539 5.175 
* Indicates significant result 
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Table 5: Frequency of Selecting Correct Answer 
 Pre-Intervention Post-Intervention Follow-Up 
Question 1: HPV can cause the following: 
Percentage (n) change from 
pre 
83% (n=62) 86% (n=64) +2 68% (n=50) -12 
Question 2: Oral cancer caused by HPV can be detected in the following ways: 
Percentage (n) change from 
pre 
32% (n=24) 78% (n=58) +34 14% (n=10) -12 
Question 3: According to D’Souza, what is considered a high lifetime number of oral-sex 
partners? 
Percentage (n) change from 
pre 
72% (n=54) 92% (n=68) +14 61% (n=45) -9 
Attitude Questions 
Question 4: I am knowledgeable about the potential of HPV to cause oral cancer. 
Percentage of Strongly 
Agree and Agree (n) change 
from pre 
84% (n=63) 96% (n=71) +8 72% (n=53) -10 
Question 5: In the past 3 months I have taken every opportunity to speak with patients 
about the potential of HPV causing oral cancer. 
Percentage of Strongly 
Agree and Agree (n) change 
from pre 
44% (n=33) N/A 73% (n=53) +20 
 
